# CISATRACURIUM BESYLATE
> **ANDA213527** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2020-09-01
## Drug
- **FDA Application Number:** ANDA213527
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** Cisatracurium Besylate
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** ZYDUS PHARMS
- **First approval:** 2020-09-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213527)
---
*AI Analytics · CC0 1.0*